Simplifying Global Compliance
Lawmakers Blast FDA’s Decision To Approve Opioid Zohydro ER
Washington Drug Letter
Several House members are calling on the FDA to strip Zohydro ER, Zogenix’s opioid painkiller, of its approval until the company can instill an abuse-deterrent formulation of the product.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing